As CD44 is widely accepted as one of the most reliable cancer stem cell markers in various kinds of cancer [42,43], and because BSH-polyR directly binds to the CD44 cell-surface protein as shown above, we thought that BSH-polyR could be a promising cancer stem cell-directed 10B agent. This evidence concerns the gene CD44 and cancer.